CURRENT
ISSUE
1619

The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride (Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved earlier.

COLONOSCOPY PREPARATIONS — Traditional polyethylene glycol (PEG) plus electrolytes solutions for bowel cleansing prior to colonoscopy are isotonic and require patients to ingest up to 4 L of fluid to produce a cathartic effect....  Continue reading

More from Issue 1619
Previous Issue: 1618      February 22, 2021
Coming Soon
Low-Dose Colchicine for Coronary Artery Disease
Drugs for Multiple Sclerosis
Semaglutide (Ozempic) for Weight Loss
In Brief: Hypertension with Erenumab (Aimovig)
Search
Donate
Subscribe
Conversation
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
Advance Release
ADVANCE
RELEASE

On February 27, 2021, the FDA issued an Emergency Use Authorization (EUA) for the Johnson & Johnson adenovirus-based vaccine for prevention of COVID-19 in persons ≥18 years old. It is the third COVID-19 vaccine to become available in the US and the first to require only a single dose. Two-dose mRNA-based vaccines manufactured by Pfizer-BioNTech and Moderna received EUAs in December ... Continue reading

 Tweets